Loading insider details...
Beta
Latest Form 4 (Sep 11, 2026): Exercise/Conversion of 10,000 TVTX shares, $174.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 10,000 | $174.4K |
| May 21, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 4,000 | n/a |
| May 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 8,000 | $130.6K |
| Feb 13, 2026 | Indaptus Therapeutics, Inc. (INDP) | Disposition to Issuer | 3,033 | n/a |
| Dec 29, 2025 | Indaptus Therapeutics, Inc. (INDP) | Grant/Award | 216,617 | $439.7K |
| Jul 29, 2025 | Indaptus Therapeutics, Inc. (INDP) | Grant/Award | 6,068 | $50.4K |
| May 16, 2025 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 6,500 | n/a |
| Apr 11, 2025 | Indaptus Therapeutics, Inc. (INDP) | Disposition to Issuer | 4,750 | $175.75 |
| Nov 26, 2024 | Indaptus Therapeutics, Inc. (INDP) | Grant/Award | 42,553 | $50.0K |
| Oct 10, 2024 | Indaptus Therapeutics, Inc. (INDP) | Grant/Award | 75,000 | n/a |